---
id: 187
title: Adult Vaccination Schedule
category: vaccines
subcategory: immunization
tags: [vaccines, immunization, ACIP, adult, influenza, pneumococcal, Tdap, shingles]
difficulty: medium
---

## Question

What vaccines do adults need? Use **"Annual: Flu, Every 10y: Td/Tdap, Age ≥50: Shingles, Age ≥65: Pneumococcal"** framework.

## Answer

### **Universal Adult Vaccines:**

**Influenza (Flu):**
- **Annual** (all adults ≥6 months)
- **Timing:** Fall (September-October ideal), but give anytime during flu season

**Tdap/Td (Tetanus, Diphtheria, Pertussis):**
- **Tdap × 1** (if not received as adolescent/adult)
- **Td boosters every 10 years**
- **Pregnancy:** Tdap **each pregnancy** (27-36 weeks) - protects newborn from pertussis

**COVID-19:**
- **Updated vaccine annually** (all adults, per CDC recommendations)

### **Age-Based Vaccines:**

**Pneumococcal (≥65 Years OR High-Risk):**

**Immunocompetent ≥65 Years:**
- **PCV20 (Prevnar 20) × 1** (single dose, preferred)
- OR **PCV15 (Prevnar 15) × 1 → PPSV23 (Pneumovax 23) ≥1 year later**

**High-Risk <65 Years:** Same as ≥65 (chronic lung/heart/liver disease, diabetes, smoking, alcoholism, asplenia, immunocompromised)

**Shingles (Herpes Zoster):**
- **Recombinant zoster vaccine (RZV, Shingrix):** **2 doses (0, 2-6 months)**
- **Age:** **≥50 years** (preferred) OR ≥19 years if immunocompromised
- **Give even if:** Prior shingles episode, prior live zoster vaccine (Zostavax)

### **Risk-Based Vaccines:**

**Hepatitis A:**
- **2 doses (0, 6-18 months)**
- **Indications:** Chronic liver disease, MSM, IVDU, travelers to endemic areas, homelessness

**Hepatitis B:**
- **3 doses (0, 1, 6 months)** OR **2-dose series (Heplisav-B: 0, 1 month for adults ≥18 years)**
- **Indications:** ESRD/dialysis, HIV, HCV, IVDU, multiple sex partners, healthcare workers, diabetes <60 years
- **Universal for all adults 19-59 years** (2022 CDC recommendation)

**HPV (Human Papillomavirus):**
- **2-3 doses** (0, 1-2, 6 months)
- **Age:** 11-26 years (routine), 27-45 years (shared decision-making)

**MMR (Measles, Mumps, Rubella):**
- **1-2 doses** (if no evidence of immunity)
- **Indications:** Born ≥1957 without documented immunity, healthcare workers, international travelers

**Varicella (Chickenpox):**
- **2 doses (0, 4-8 weeks)** if no evidence of immunity (no history of chickenpox, no vaccine, seronegative)

**Meningococcal:**
- **MenACWY:** College students (dorm), asplenia, complement deficiency, travel to endemic areas, military recruits
- **MenB:** Asplenia, complement deficiency, outbreak settings

**RSV (Respiratory Syncytial Virus):**
- **Single dose** (adults ≥60 years, shared decision-making)
- **Pregnancy:** 32-36 weeks (protects newborn via maternal antibodies)

### **Immunocompromised-Specific:**

**Asplenia/Complement Deficiency:**
- **Meningococcal (MenACWY, MenB), *H. influenzae* type b (Hib), pneumococcal (PCV20 or PCV15 + PPSV23)**

**HIV:**
- **All routine vaccines** (live vaccines if CD4 >200)
- **Additional:** Pneumococcal (PCV20 or PCV15 + PPSV23), meningococcal, hepatitis A/B

**Solid Organ Transplant:**
- **Ideally vaccinate before transplant**
- **Post-transplant:** Avoid live vaccines, inactivated vaccines OK (but reduced efficacy)

## Key Points

### **Live vs. Inactivated Vaccines:**

**Live Vaccines (Contraindicated in Severe Immunosuppression):**
- **MMR, varicella, live zoster (Zostavax), intranasal flu (FluMist), yellow fever**
- **Avoid if:** HIV CD4 <200, high-dose steroids (≥20mg prednisone × ≥2 weeks), biologics, transplant

**Inactivated/Subunit Vaccines (Safe in Immunocompromised):**
- **Flu (injectable), Tdap, pneumococcal, hepatitis A/B, HPV, meningococcal, RZV (Shingrix)**

### **Shingrix (RZV) = Preferred Over Zostavax:**
- **Recombinant (NOT live)** - safe in immunocompromised
- **Higher efficacy** (>90% vs. 50% for Zostavax)
- **2 doses (0, 2-6 months)**

### **Pneumococcal: PCV20 Simplifies Regimen:**
- **Single dose PCV20** (preferred) vs. PCV15 + PPSV23 (2 doses)
- **Covers 20 serotypes** (vs. 15 + 23)

### **Pregnancy Vaccines:**
- **Safe:** Tdap (each pregnancy, 27-36 weeks), flu (any trimester), COVID-19, RSV (32-36 weeks)
- **Avoid:** Live vaccines (MMR, varicella, Zostavax)

### **Clinical Pearls:**
- **Annual:** Flu (all adults), COVID-19
- **Every 10 years:** Td (Tdap × 1 if not received)
- **Age ≥50:** Shingrix (RZV) 2 doses
- **Age ≥65:** Pneumococcal (PCV20 preferred single dose)
- **Pregnancy:** Tdap each pregnancy (27-36 weeks), flu, COVID-19, RSV (32-36 weeks)
- **Immunocompromised:** Avoid live vaccines (except RZV, which is inactivated)

## Sources

- [CDC/ACIP: Adult Immunization Schedule 2024]
- [IDSA: Vaccination of Immunocompromised Hosts 2024]

## Media

N/A
